COSCIENS Biopharma Inc. (CSCI) — Capital Reinvestment Ratio
COSCIENS Biopharma Inc. (CSCI) has a Capital Reinvestment Ratio of 0.06x as of September 2023, meaning it reinvests 0% of its operating cash flow ($144.00K) in capital expenditures ($8.92K). Check tangible net worth ratio of COSCIENS Biopharma Inc. to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
COSCIENS Biopharma Inc. Capital Reinvestment Ratio (2003–2022)
This chart tracks COSCIENS Biopharma Inc.'s Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see COSCIENS Biopharma Inc. (CSCI) cash flow conversion.
Annual Capital Reinvestment Ratio for COSCIENS Biopharma Inc. (2003–2022)
Year-by-year Capital Reinvestment Ratio for COSCIENS Biopharma Inc. from 2003 to 2022. See cash generation quality of COSCIENS Biopharma Inc. to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.00x | $5.23 Million | $10.57K | ▼ -99.0% |
| 2021 | 0.20x | $2.75 Million | $555.99K | ▲ +45.3% |
| 2020 | 0.14x | $3.49 Million | $485.46K | ▲ +2689786.0% |
| 2019 | 0.00x | $675.29K | $3.49 | ▼ -100.0% |
| 2017 | 2.55x | $1.25 Million | $3.20 Million | ▲ +150.5% |
| 2016 | 1.02x | $3.63 Million | $3.71 Million | ▼ -3.5% |
| 2015 | 1.06x | $2.87 Million | $3.03 Million | ▼ -51.2% |
| 2014 | 2.16x | $1.84 Million | $3.98 Million | ▼ -54.0% |
| 2013 | 4.70x | $460.21K | $2.16 Million | ▲ +2917.9% |
| 2011 | 0.16x | $791.62K | $123.30K | ▼ -12.1% |
| 2010 | 0.18x | $479.50K | $85.01K | ▼ -62.7% |
| 2006 | 0.47x | $140.59K | $66.73K | ▼ -74.9% |
| 2003 | 1.89x | $54.42K | $103.05K | — |